The effect of various inflammatory agents on the alternative metabolic pathways of arginine in mouse and rat macrophages

Inflammation Research

Volumn 55, Issue 1, 2006, Pages 23-31

  Hrabak A ^a   Bajor, T ^b   Csuka, I ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Kaba Elzett Rt   (Hungary)

Author keywords

Arginase; Arginine metabolism; Inflammation; Macrophages; Nitric oxide

Indexed keywords

ARGINASE; BCG VACCINE; CARRAGEENAN; CASEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NEWCASTLE DISEASE VACCINE; NITRIC OXIDE; THIOGLYCOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME METABOLISM; INFLAMMATION; MACROPHAGE; MALE; METABOLISM; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; ARGINASE; ARGININE; BCG VACCINE; CARRAGEENAN; CASEINS; INFLAMMATION; MACROPHAGES; MALE; MICE; NEWCASTLE DISEASE VIRUS; NITRIC OXIDE SYNTHASE TYPE II; PERITONEUM; RATS; RATS, WISTAR; THIOGLYCOLATES; VIRAL VACCINES;

EID: 31344444723     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-005-0004-6     Document Type: Article

References (44)

1. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003; 54: 469-87.
2. Abramson SB, Amin AR, Clancy RM, Attur M. The role of nitric oxide in tissue destruction. Best Pract Res Clin Rheumatol 2001; 15: 831-45.
3. Wallace JL. Nitric oxide-releasing mesalamine: Potential utility for treatment of inflammatory bowel disease. Digest Liver Dis 2003; 35: S35-40.
4. von Haehling S, Anker SD, Bassenge E. Statins and the role of nitric oxide in chronic heart failure. Heart Failure Rev 2003; 8: 99-106.
5. Favaloro FG Jr, Honda T, Honda Y, Gribble GW, Suh N, Risingsong R, Sporn MB. Design and synthesis of tricyclic compounds with enone functionalities in rings A and C. A novel class of highly active inhibitors of nitric oxide production in mouse macrophages. J Med Chem 2002; 45: 4801-5.
6. Ryu SY, Jeong KS, Kang BN, Park SJ, Yoon WK, Kim SH, Kim TH. Modulation of transferrin synthesis, transferrin receptor expression, iNOS expression and NO production in mouse macrophages by cytokines, either alone or in combination. Anticancer Res 2000; 20: 3331-8.
7. Davies JQ, Gordon S. Isolation and culture of murine macrophages. Methods in Mol Biol 2005; 290: 91-103.
8. Knudsen E, Benestad HB, Seierstad T, Iversen PO. Macrophages in spleen and liver direct the migration pattern of rat neutrophils during inflammation. Eur J Haematol 2004; 73: 109-22.
9. Miyamoto M, Sato EF, Nishikawa M, Nishizawa Y, Morii H, Inoue M. Effect of endogenously generated nitric oxide on the energy metabolism of peritoneal macrophages. Physiol Chem Phys Med NMR. 2003; 35: 1-11.
10. Conde M, Andrade J, Bedoya FJ, Santa Maria C, Sobrino F. Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity. Immunology 1995; 84: 476-81.
11. Cuzzocrea S, Mazzon E, Sautebin L, Serraino I, Dugo L, Calabro G, Caputi AP, Maggi A. The protective role of endogeneous estrogens in carrageenan-induced lung injury in the rat. Mol Med 2001; 7: 478-87.
12. Nacife VP, Soeiro MD, Araujo-Jorge TC, Castro-Faria Neto HC, Meirelles MD. Ultrastructural, immunocytochemical and flow cytometry study of mouse peritoneal cells stimulated with carrageenan. Cell Struct Funct 2000; 25: 337-50.
13. Nascimento FR, Ribeiro-Dias F, Russo M. Cytotoxic activity of BCG-activated macrophages against L929 tumor cells is nitric oxide-dependent. Braz J Med Biol Res 1998; 31:1593-96.
14. Kleinert H, Schwarz PM, Forstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem 2003; 384: 1343-64.
15. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15: 323-50.
16. Müllner N, Lázár Á, Hrabák A. Enhanced utilization and altered metabolism of arginine in inflammatory macrophages caused by raised nitric oxide synthesis. Int J Biochem Cell Biol 2002; 34: 1080-90.
17. Werneck-Barroso E, Novaes Moura AC, Dias Fernandes P, Crus Rosas E, Assreuy J, das Gracas M, O, Henriques M. Nitric oxide production by BCG-infected pleural macrophages from C57B1/6 and DBA-2 mice. Int J Mol Med 2000; 5: 95-9.
18. Fremond CM, Nicolle DM, Torres DS, Quesniaux VF. Control of Mycobacterium bovis BCG infection with increased inflammation in TLR-4 deficient mice. Microbes Infect 2003; 5: 1070-81.
19. Vanguri P, Farber J. IFN and virus-induced expression of an early gene crg-2/IP-10 and a delayed gene I-A alpha in astrocytes and microglia. J Immunol 1994; 152: 1411-18.
20. Nelson CB. An outbreak of conjunctivites due to Newcastle disease virus (NDV) occurring in poultry workers. Am J Public Health 1952; 42: 672-8.
21. Hrabák A, Sefrioui H, Vercuysse V, Temesi Á, Bajor T, Vray B. Action of chloroquine on nitric oxide production and parasite killing by macrophages. Eur J Pharmacol 1998; 354: 83-90.
22. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
23. Coulombe JJ, Favreau L. A new simple semimicro method for colorimetric determination of urea. Clin Chem 1963; 9: 102-8.
24. Hrabák A, Antoni F, Csuka I. Differences in the arginase activity produced by resident and stimulated murine and rat peritoneal macrophages. Int J Biochem 1991; 23: 997-1003.
25. Hrabák A, Antoni F, Csuka I. Evidence for the pre-synthesized state of secreted macrophage arginase: arginase cannot be modified in short-term cultures. Acta Physiol Hung 1993; 81: 45-57.
26. Hrabák A, Bajor T, Temesi Á Comparison of substrate and inhibitor specificity of arginase and nitric oxide synthase for arginine analogues and related compounds in murine and rat macrophages. Biochem Biophys Res Commun 1994; 198: 206-12.
27. Farkas Á, Vámos R, Bajor T, Müllner N, Lázár Á, Hrabák A. Utilization of lacrimal urea assay in the monitoring of hemodialysis: conditions, limitations and lacrimal arginase characterization. Exp Eye Res 2003; 76: 183-92.
28. Munder M, Eichmann K, Modolell M. Alternative metabolic states in murine macrophages reflected by nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotypes. J Immunol 1998; 160: 5347-54.
29. Schirrmacher V, Bai L, Umansky V, Yu L, Xing Y, Qian Z. Newcastle disease virus activates macrophages for anti-tumor activity. Int J Oncol 2000; 16: 363-73.
30. Umansky V, Shatrov VA, Lehmann V, Schirrmacher V. Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-kappa B. Int Immun 1996; 8: 491-98.
31. Hrabák A, Csuka I, Bajor T, Csatáry LK. The cytotoxic anti-tumor effect of MTH-68/H, a live attenuated Newcastle Disease Virus is mediated by the induction of nitric oxide synthesis in rat peritoneal macrophages in vitro. Cancer Lett 2005; in press, doi: 10.1016/j.canclet.2005. 02.008
32. Nathan CF, Xie Qw. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269: 13725-8.
33. Jaramillo M, Naccache PH, Olivier M. Monosodium urate crystals synergize with IFN-gamma to generate macrophage nitric oxide: involvement of extracellular signal-regulated kinase 1/2 and NF-kappa B. J Immunol 2004; 172: 5734-42.
34. Wen J, Han M, Liu D. Molecular cloning and characterization of the promoter region of the inducible nitric oxide synthase gene of the rat. Biochemistry-Russia. 2000; 65:1327-30.
35. Zhang H, Chen X, Teng X, Snead C, Catravas JD. Molecular cloning and analysis of the rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells. Biochem Pharmacol 1998; 55:1873-80.
36. Benninghoff B, Dröge W, Lehmann V. The lipopolysaccharide-induced stimulation of peritoneal macrophages involves at least two signal pathways. Partial stimulation by lipid A precursors. Eur J Biochem 1989; 179: 589-94.
37. Iniesta V, Gómez-Nieto GC, Molano I, Mohedano A, Carcelén J, Mirón C, Alonso C, Corraliza I. Arginase I induction in macrophages, triggered by Th-2 type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol 2002; 24: 113-8.
38. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000; 164: 6166-73.
39. Sonoki T, Nagasaki A, Gotoh T, Takiguchi M, Takeya M, Matsuzaki H, Mori M. Coinduction of nitric oxide synthase and arginase I in cultured rat peritoneal macropahges and rat tissues in vivo by lipopolysaccharide. J Biol Chem 1997; 272: 3689-93.
40. Hrabák A, Temesi Á, Csuka I, Antoni F. Inverse relation in the de novo arginase synthesis and nitric oxide production in murine and rat peritoneal macrophages in long-term cultures in vivo. Comp Biochem Physiol 1992; 103B: 839-45.
41. Kanyo ZF, Scolnick LR, Ash, DE, Christianson DW. Structure of a unique binuclear manganese cluster in arginase. Nature 1996; 383: 554-7.
42. Wu G, Brosnan JT. Macrophages can convert citrulline to arginine. Biochem J 1992; 281: 45-8.
43. Nagasaki A, Gotoh T, Takeya M, Yu Y, Takiguchi M, Matsuzaki H, Takatsuki K, Mori M. Coinduction of nitric oxide synthase, argininosuccinate synthetase and argininosuccinate lyase in lipopolysaccharide treated rats. RNA blot, immunoblot and immunohistochemical analyses. J Biol Chem 1996; 271: 2658-72.
44. Hrabák A, Idei M, Temesi Á. Arginine supply for nitric oxide synthesis and arginase is mainly exogeneous in elicited murine and rat macrophages. Life Sci 1994; 55: 797-805.